Zimmerman, J., Snyder, M., John, M. S., Secord, A. A., Wright, J., Lightfoot, M., … Crafton, S. (2026). Exploring the clinical application and outcomes of the FIGO 2023 endometrial cancer staging system in early-stage disease. In Gynecologic Oncology (Vol. 208, pp. S272–S273). Elsevier BV. https://doi.org/10.1016/j.ygyno.2026.01.486

Zimmerman, Jenna, Megan Snyder, Meghan St John, Angeles Alvarez Secord, Jason Wright, Michelle Lightfoot, Victoria Bae-Jump, et al. “Exploring the clinical application and outcomes of the FIGO 2023 endometrial cancer staging system in early-stage disease.” In Gynecologic Oncology, 208:S272–73. Elsevier BV, 2026. https://doi.org/10.1016/j.ygyno.2026.01.486.

Zimmerman J, Snyder M, John MS, Secord AA, Wright J, Lightfoot M, et al. Exploring the clinical application and outcomes of the FIGO 2023 endometrial cancer staging system in early-stage disease. In: Gynecologic Oncology. Elsevier BV; 2026. p. S272–3.

Zimmerman, Jenna, et al. “Exploring the clinical application and outcomes of the FIGO 2023 endometrial cancer staging system in early-stage disease.” Gynecologic Oncology, vol. 208, Elsevier BV, 2026, pp. S272–73. Crossref, doi:10.1016/j.ygyno.2026.01.486.

Zimmerman J, Snyder M, John MS, Secord AA, Wright J, Lightfoot M, Bae-Jump V, Mullen M, Clements A, Yin Y, Krivak T, Miller E, Horne Z, Nakayama J, Morse C, Wield A, Crafton S. Exploring the clinical application and outcomes of the FIGO 2023 endometrial cancer staging system in early-stage disease. Gynecologic Oncology. Elsevier BV; 2026. p. S272–S273.